ReviewFrontiers in endocrinology2026

Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy.

Libin Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.